SCHEMBL8351027

SCHEMBL8351027

Cc1ccc(C2(CO)CCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 8/20 0.41
SLC6A2 P23975 5/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
PRKAB2 O43741 4/20 0.38
PRKAG1 P54619 4/20 0.38
PRKAA2 P54646 4/20 0.38
PRKAA1 Q13131 4/20 0.38
PRKAG3 Q9UGI9 4/20 0.38
PRKAG2 Q9UGJ0 4/20 0.38
PRKAB1 Q9Y478 4/20 0.38
SLC6A3 Q01959 7/20 0.37
HSD11B1 P28845 1/20 0.36
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15866841 0.96 SLC6A4 (0.41) SLC6A4SLC6A2L3MBTL1SLC6A3HSD11B1
SCHEMBL8353941 0.91 L3MBTL1 (0.41) SLC6A4SLC6A2L3MBTL1PRKAB2PRKAG1
SCHEMBL15356033 0.81 PDE4A (0.48) SLC6A4L3MBTL1PRKAB2PRKAG1PRKAA2
SCHEMBL17888243 0.81 OPRM1 (0.50) SLC6A3
SCHEMBL2321615 0.79 ALDH1A1 (0.43) SLC6A4SLC6A2L3MBTL1PRKAB2PRKAG1
SCHEMBL13106860 0.79 MAOB (0.39) SLC6A4SLC6A2L3MBTL1SLC6A3MAOA
SCHEMBL17080542 0.79 SLC6A4 (0.41) SLC6A4SLC6A2PRKAB2PRKAG1PRKAA2
SCHEMBL8353188 0.79 DPP4 (0.59) SLC6A4SLC6A2SLC6A3MAOAMAOB
SCHEMBL6014515 0.79 ALDH1A1 (0.47) SLC6A4SLC6A2L3MBTL1PRKAB2PRKAG1
SCHEMBL2129 0.79 SLC6A4 (0.58) SLC6A4SLC6A2PRKAB2PRKAG1PRKAA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed